/PRNewswire/ VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, has issued a Business Review of 2022, outlining.
VolitionRx Limited (NYSE:NYSE:VNRX) Q3 2022 Earnings Conference Call November 15, 2022 8:30 AM Company Participants Scott Powell - IR Cameron Reynolds - Founder, Group CEO Tom Butera - CEO,.
/PRNewswire/ VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced financial results and a business update for the third quarter ended.
/PRNewswire/ VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced financial results and a business update for the third quarter ended.
VolitionRx Limited Announces Second Quarter 2022 Financial Results and Business Update streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.